All In Biotech

Free tool

FAERS Monitor: Nexterone

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022325 or its brand name (Nexterone, Amiodarone Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

9,437

Serious

8,191

87% of reports

Hospitalization

4,651

Death reported

1,606

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea1,008
  • off label use869
  • asthenia837
  • fatigue779
  • drug ineffective712
  • product use in unapproved indication648
  • nausea548
  • cough532
  • atrial fibrillation476
  • dizziness476
  • drug interaction454
  • pneumonia452
  • vomiting440
  • hypotension431
  • condition aggravated411

Reports by year received

View as table
YearReports
200459
2005106
200683
200768
200841
2009108
2010119
2011140
2012338
2013144
2014149
2015187
2016218
2017504
2018500
2019619
2020605
2021843
2022940
2023941
20241,058
20251,049
2026616

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,044,722 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
atrial fibrillationSignal47610.910.04,289
drug interactionSignal4546.45.82,070
product use in unapproved indicationSignal6485.85.42,619
astheniaSignal8375.04.72,693
hypotensionSignal4314.84.41,301
coughSignal5324.23.91,326
dyspnoeaSignal1,0084.03.72,298
pneumoniaSignal4523.12.8656
condition aggravatedSignal4113.02.7559
fatigueSignal7792.22.1548
off label useSignal8692.22.1601
dizzinessSignal4762.11.9290
vomitingSignal4402.11.9253
nausea5481.51.4108
drug ineffective7121.21.126

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.